In summary, the major effects of MLC901 are the reduction of neutrophil recruitment, the reduction of microglia activation and the reduction of pro-inflammatory mediators (TNFα, IL6, IL1β, CCL2) production induced by stroke. This evidence concerns the gene CCL2 and Stroke.